http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101203251-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716e9a2606ffd4ba1a2a3917e4a402fd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-717
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-717
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
filingDate 2006-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d640902acd1ffacf5665cf91e65bac1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48794e8650aef64c4f674f634671ee90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aa18995be48fb7bf01400dc000e4eba
publicationDate 2008-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101203251-A
titleOfInvention Vitreous body visualization agent
abstract An agent for visualizing vitreous body which is to be injected into the eye to visualize the vitreous body by a safe and sure method. The agent for visualizing vitreous body is prepared by using a high-molecule substance having a positively or negatively charged functional group and adding a hardly water-soluble and nonsteroidal colored substance, in which the high-molecule substance is to be suspended, thereto. Because of having a nonsteroidal nature, it can be safely injected into the eye and the colored substance, in which the high-molecule substance is to be suspended, makes the vitreous body visually recognizable.
priorityDate 2005-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36375
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31307
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447827056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25199600

Total number of triples: 46.